News and Updates
iVeena to present at the BioTech Showcase Conference that runs in parallel with the JP Morgan Conference in San Francisco on Wednesday, January 11, 2017
iVeena to present at the BioTech Showcase Conference that runs in parallel with the JP Morgan Conference in San Francisco on Wednesday, January 11, 2017
iVeena has been awarded a $150K 2017 USTAR Technology Acceleration Grant to advance development of IVMED-70, our innovative Glaucoma MIGS (Minimally Invasive Glaucoma Stent) device.
Glaucoma affects approximately three million individuals in the US and can lead to blindness if not treated. The current standard of care is to administer eye drops on a daily basis that results in a...
iVeena appoints Peter Hnik, MD, MHSc as Chief Medical Officer to oversee expanding clinical program.
Dr. Peter Hnik Appointed Chief Medical Officer Peter Hnik, MD, MHSc has been appointed Chief Medical officer of iVeena Delivery Systems Inc. Dr. Hnik will oversee the expansion of the iVeena clinica...
iVeena announces the appointment of Alan Crandall, M.D. to the iVeena Scientific Advisory Board to expand its Glaucoma program
Alan Crandall, M.D. is considered a world authority in the research and treatment of glaucoma. Dr. Crandall has chaired more than 150 major national and international symposia. He has co-authored two...
iVeena announces the initiation of its Scientific Advisory Board with the appointment of three prominent ophthalmologists and Opinion Leaders in their respective disciplines.
Formation of iVeena Scientific Advisory Board: iVeena announces appointment of Edward Holland, MD., Director of Cornea Services at Cincinnati Eye Institute and Professor of Ophthalmology at the Univ...
Page 6 of 9